In 2023, the re-import of electro-cardiographs to France was recorded at 426.25 thousand US dollars. From this point, the forecasted values depict a steady upward trend from 2024 to 2028, with a consistent annual increase. Specifically, the predicted year-on-year percentage changes are approximately 2.3% from 2024 to 2025, 2.2% from 2025 to 2026, 2.1% from 2026 to 2027, and 2.0% from 2027 to 2028. Over the span of five years, the compound annual growth rate (CAGR) is about 2.15%, indicating solid growth in this sector.
Future trends to watch for include technological advancements in electro-cardiographs, changes in global trade policies potentially influencing re-import practices, and variations in domestic demand for these medical devices. Additionally, monitoring competitors' developments and healthcare policy shifts in France will be crucial for anticipating shifts in re-import volumes.
